arion venture capital | Fonds d'investissement
Description: EpiLAB is developing a portable screening test for tuberculosis, to diagnose the 3 million cases undetected each year, of the world’s top infectious killer.
Tuberculosis
epilab test
tuber Tuberculosis In Figures 10 Million New Cases Each Year Each year, 10 million people contract tuberculosis. One-third of these new cases, representing about 3 million individuals, are not detected and remain unknown to health organisations. As a result, patients are not receiving appropriate treatment, thereby allowing for ongoing disease transmission. 4 Million Undetected Cases ​Eighty percents of new yearly cases emerge in developing countries that lack resources to implement successful diagnosis cam
arion venture capital | Fonds d'investissement